NRXP Q1 2026 Earnings Revenueless Biotech Reports EPS Miss but Stock Surges 34 RAVE Q3 2024 Earnings Positive EPS Amid Limited Visibility Stock Declines HBANP Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Banking Environment CSAN Q1 2026 Earnings Heavy Losses as EPS Misses Estimates by a Wide Margin HCWC Q4 2025 Earnings Narrow Beat on EPS Provides Modest Relief Amid Stalled Revenue Disclosure LSBK Q3 2025 Earnings Steady Profitability Amidst Stable Operations